Table 4.

Loss of dorsal CST axons in the lumbar spinal cords of MOG peptide EAE mice is bilaterally symmetric

Days post-MOG peptide	Treatment	Axon count		r²
Days post-MOG peptide	Treatment	Right	Left	r²
Normal	Untreated	2823	2945
35	CFA 1	3116	3010
101	CFA 1	2830	3069
101	CFA 2	2937	3120
				0.997
35	MOG peptide 1	1982	2329
35	MOG peptide 2	1804	1955
35	MOG peptide 3	1819	1489
35	MOG peptide 4	1593	1937
35	MOG peptide 5	702	979
35	MOG peptide 6	1776	1659
				0.974
101	MOG peptide 7	275	307
101	MOG peptide 8	247	215
101	MOG peptide 9	397	536
101	MOG peptide 10	1870	1335
				0.956

EYFP⁺ axons were counted in the right and left dorsal corticospinal tracts in L3 spinal cord cross-sections from normal, CFA control, and MOG peptide EAE EmxCre/RosaSTOP-EYFP mice. The regression coefficient r² was close to 1 in each group, indicating little variance between the axon counts on the right and left side in either the control or MOG peptide EAE mice (Snedecor and Cochran, 1989).